Clinical Trial Update: Terlipressin Administration in Patients Undergoing Major Liver Resection [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating terlipressin in patients undergoing major liver resection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Liver Resection, Liver Failure | Phase 2 | Status: TERMINATED